Crossmark

Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials

Crossref DOI link: https://doi.org/10.1186/s12916-015-0358-8

Published Online: 2015-06-23

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xin-Lin

Zhu, Qing-Qing

Zhu, Li

Chen, Jian-Zhou

Chen, Qin-Hua

Li, Guan-Nan

Xie, Jun

Kang, Li-Na

Xu, Biao
License Information

License valid from 2015-06-23
More Information

Article History

Received: 11 February 2015

Accepted: 30 April 2015

First Online: 23 June 2015